These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 24658320

  • 1. Differential expression of STAT1 and p21 proteins predicts pancreatic cancer progression and prognosis.
    Sun Y, Yang S, Sun N, Chen J.
    Pancreas; 2014 May; 43(4):619-23. PubMed ID: 24658320
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion.
    Lenz J, Karasek P, Jarkovsky J, Muckova K, Dite P, Kala Z, Veselska R, Hermanova M.
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):389-96. PubMed ID: 22187705
    [Abstract] [Full Text] [Related]

  • 3. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
    Chen HT, Cai QC, Zheng JM, Man XH, Jiang H, Song B, Jin G, Zhu W, Li ZS.
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
    [Abstract] [Full Text] [Related]

  • 4. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL, Li DD, Lin Q, Zhou Y, Zhou QB, Zeng B, Fu ZQ, Gao WC, Liu YM, Chen RW, Li ZH, Chen RF.
    World J Gastroenterol; 2015 Jun 07; 21(21):6621-30. PubMed ID: 26074700
    [Abstract] [Full Text] [Related]

  • 5. Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis.
    Gunia S, Kakies C, Erbersdobler A, Hakenberg OW, Koch S, May M.
    J Clin Pathol; 2012 Mar 07; 65(3):232-6. PubMed ID: 22135025
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA, Kench JG, Segara D, Coleman MJ, Sutherland RL, Henshall SM, Musgrove EA, Biankin AV.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct 07; 15(10):1941-7. PubMed ID: 17035403
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH, Heo JH, Kim TH, Kang H, Kim G, Kim J, Cho SH, An HJ.
    Int J Gynecol Pathol; 2011 May 07; 30(3):205-17. PubMed ID: 21464733
    [Abstract] [Full Text] [Related]

  • 11. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
    Fong D, Spizzo G, Mitterer M, Seeber A, Steurer M, Gastl G, Brosch I, Moser P.
    Ann Surg Oncol; 2012 Dec 07; 19(13):4330-6. PubMed ID: 22549289
    [Abstract] [Full Text] [Related]

  • 12. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK, Beck AH, Mitchem J, Linehan DC, Chang DT, Norton JA, Pai RK.
    Am J Surg Pathol; 2011 Feb 07; 35(2):228-34. PubMed ID: 21263243
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    Liver Int; 2007 Aug 07; 27(6):772-81. PubMed ID: 17617120
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, Yachida S.
    Ann Surg; 2013 Aug 07; 258(2):336-46. PubMed ID: 23470568
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
    Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, Arriaga Y, Bolenz C, Margulis V, Raj GV, Sagalowsky AI, Shariat SF.
    Eur Urol; 2013 Sep 07; 64(3):465-71. PubMed ID: 23571005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.